3 results

  • amvuttra

    (VUTRISIRAN)
    Alnylam Pharmaceuticals, Inc.
    AMVUTTRA is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.

  • givlaari

    (givosiran sodium)
    Alnylam Pharmaceuticals, Inc.
    GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP).

  • onpattro

    (patisiran)
    Alnylam Pharmaceuticals, Inc.
    ONPATTRO is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.